$179.01+0.18 (+0.10%)
Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities in the United States.
Universal Health Services, Inc. in the Healthcare sector is trading at $179.01 with a market capitalization of $10.6B. Wall Street consensus targets $194.94 (17 analysts), implying a +8.9% move over the next 12 months. The stock is currently 27% below its 52-week high of $246.33, remaining 0.2% above its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $4.64B↑ | $4.50B↑ | $4.49B↓ | $4.50B↑ | $4.28B |
| Gross Profit | $4.21B↑ | $4.07B↑ | $4.06B↓ | $4.08B↑ | $3.87B |
| Operating Income | $516.67M↑ | $502.86M↓ | $517.23M↓ | $521.69M↑ | $500.27M |
| Net Income | $358.45M↑ | $348.68M↓ | $445.94M↑ | $372.96M↑ | $353.22M |
Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities in the United States. It operates through Acute Care Hospital Services and Behavioral Health Care ...
Academic risk and quality models computed from UHS's own filings and price history, not from analyst opinion.
Strong on 8 of 9 fundamental-health tests covering profitability, leverage and operating efficiency.
Altman Z above the 2.99 safe threshold, so the model puts bankruptcy risk in its lowest band.
Beneish M below the -1.78 flag threshold, so the earnings-manipulation model finds nothing unusual in the accruals and margin trends.
Share of earnings coming from accruals rather than cash. Higher values historically precede weaker future returns.
GARCH(1,1) 30-day annualised forecast, above the current 30.3% reading.
Fama-French 5-factor market beta. The five factors explain 16% of this stock's return variance; the rest is idiosyncratic.
The stock’s own historical valuation anchor, which is a fairer comparison than a sector average for a company with a persistent premium or discount.
Model inputs as of 2026-10-13.